JP7445966B2 - 糖鎖を解析する方法 - Google Patents

糖鎖を解析する方法 Download PDF

Info

Publication number
JP7445966B2
JP7445966B2 JP2020053296A JP2020053296A JP7445966B2 JP 7445966 B2 JP7445966 B2 JP 7445966B2 JP 2020053296 A JP2020053296 A JP 2020053296A JP 2020053296 A JP2020053296 A JP 2020053296A JP 7445966 B2 JP7445966 B2 JP 7445966B2
Authority
JP
Japan
Prior art keywords
nucleic acid
cells
labeled
lectin
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020053296A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021151206A5 (enExample
JP2021151206A (ja
Inventor
浩章 舘野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST filed Critical National Institute of Advanced Industrial Science and Technology AIST
Priority to JP2020053296A priority Critical patent/JP7445966B2/ja
Priority to PCT/JP2021/010385 priority patent/WO2021193199A1/ja
Priority to US17/913,698 priority patent/US20230117360A1/en
Publication of JP2021151206A publication Critical patent/JP2021151206A/ja
Publication of JP2021151206A5 publication Critical patent/JP2021151206A5/ja
Application granted granted Critical
Publication of JP7445966B2 publication Critical patent/JP7445966B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2020053296A 2020-03-24 2020-03-24 糖鎖を解析する方法 Active JP7445966B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2020053296A JP7445966B2 (ja) 2020-03-24 2020-03-24 糖鎖を解析する方法
PCT/JP2021/010385 WO2021193199A1 (ja) 2020-03-24 2021-03-15 糖鎖を解析する方法
US17/913,698 US20230117360A1 (en) 2020-03-24 2021-03-15 Method for analyzing sugar chain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020053296A JP7445966B2 (ja) 2020-03-24 2020-03-24 糖鎖を解析する方法

Publications (3)

Publication Number Publication Date
JP2021151206A JP2021151206A (ja) 2021-09-30
JP2021151206A5 JP2021151206A5 (enExample) 2022-12-26
JP7445966B2 true JP7445966B2 (ja) 2024-03-08

Family

ID=77886263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020053296A Active JP7445966B2 (ja) 2020-03-24 2020-03-24 糖鎖を解析する方法

Country Status (3)

Country Link
US (1) US20230117360A1 (enExample)
JP (1) JP7445966B2 (enExample)
WO (1) WO2021193199A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024048644A1 (ja) * 2022-08-30 2024-03-07 国立大学法人東京大学 担体、複合体、医薬組成物、及び診断薬
WO2025169902A1 (ja) * 2024-02-05 2025-08-14 国立研究開発法人産業技術総合研究所 神経細胞集団に残存する未分化細胞を検出または除去する方法
WO2025242912A1 (en) * 2024-05-23 2025-11-27 Institut National de la Santé et de la Recherche Médicale Conjugates for mass spectrometry imaging

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008187932A (ja) 2007-02-02 2008-08-21 National Institute Of Advanced Industrial & Technology 生細胞表層分子解析方法及び部材
JP2009219388A (ja) 2008-03-14 2009-10-01 Jsr Corp イムノｐｃｒ用磁性粒子、標的物質の検出方法、および標的物質の検出キット
JP2017507656A (ja) 2014-02-26 2017-03-23 ヴェンタナ メディカル システムズ， インク． 生物学的試料分析のための光選択的方法
JP2020503893A (ja) 2016-12-30 2020-02-06 ブリンク アーゲー 分析物の検出を行うための予め製作された微粒子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017061449A1 (ja) * 2015-10-05 2017-04-13 国立研究開発法人産業技術総合研究所 がん細胞の検出方法、がん細胞内に物質を導入するための試薬、及びがん治療用組成物
KR102556494B1 (ko) * 2017-10-31 2023-07-18 엔코디아, 인코포레이티드 핵산 암호화 및/또는 표지를 이용한 분석용 키트
US11561359B2 (en) * 2018-02-09 2023-01-24 Carl Zeiss Meditec Ag Balancing device for rotary apparatus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008187932A (ja) 2007-02-02 2008-08-21 National Institute Of Advanced Industrial & Technology 生細胞表層分子解析方法及び部材
JP2009219388A (ja) 2008-03-14 2009-10-01 Jsr Corp イムノｐｃｒ用磁性粒子、標的物質の検出方法、および標的物質の検出キット
JP2017507656A (ja) 2014-02-26 2017-03-23 ヴェンタナ メディカル システムズ， インク． 生物学的試料分析のための光選択的方法
JP2020503893A (ja) 2016-12-30 2020-02-06 ブリンク アーゲー 分析物の検出を行うための予め製作された微粒子

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中川 優，第３の生命鎖・糖鎖に結合する低分子化合物に関する現状と展望，ファルマシア，2014年，Vol. 50，pp. 1117-1122

Also Published As

Publication number Publication date
US20230117360A1 (en) 2023-04-20
WO2021193199A1 (ja) 2021-09-30
JP2021151206A (ja) 2021-09-30

Similar Documents

Publication Publication Date Title
JP7445966B2 (ja) 糖鎖を解析する方法
CN107636162B (zh) 用针对特定群体的抗原筛选t细胞的组合物和方法
US20200392479A1 (en) Single cell cellular component enrichment from barcoded sequencing libraries
AU759785B2 (en) A process to study changes in gene expression in T lymphocytes
AU2009202745A1 (en) Analysis of methylated nucleic acid
US20230103041A1 (en) Single molecule sequencing peptides bound to the major histocompatibility complex
US11560585B2 (en) Methods of identifying multiple epitopes in cells
JP5759678B2 (ja) 核酸リンカー
EP4512896A1 (en) Method and kit for identifying multifactorial interaction in biological sample
CN104088019A (zh) 一种基于双分子荧光互补技术的肽适配子文库构建方法
JP6083728B2 (ja) タンパク質機能改変法
KR101730076B1 (ko) 캠필로박터 제주니(Campylobacter jejuni)에 특이적으로 결합하는 단일가닥 DNA 압타머 및 그 제조방법
EP1291423A1 (en) Polyfunctional base sequence and artificial gene containing the same
US20220034881A1 (en) Barcoded peptide-mhc complexes and uses thereof
CN116472052A (zh) 阵列肽新表位生成器
CN120399061A (zh) 一种抗sumo2抗体的筛选和应用
WO2024261215A1 (en) High throughput screens of translation and stability of mrna using barcoded xrna display and its variations
AU2011203953B2 (en) Analysis of methylated nucleic acid
US20030060603A1 (en) Antibodies generated against polypeptide targets expressed from polynucleotide administration
KR20220095646A (ko) 엑소좀 차아집단 액체생검 샘플 제조장치 및 제조방법
JP6194894B2 (ja) 核酸リンカー
WO1984004108A1 (fr) Nouvel adn de codage de l'immunoglobuline
JP2004337022A (ja) 機能性分子及びその製造方法
Berns Isolation of calf lens messenger RNA and its translation in heterologous systems
WO2002046753A1 (en) Functional dna array

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231211

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240213

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240219

R150 Certificate of patent or registration of utility model

Ref document number: 7445966

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150